1Abulrahman Abdullahi Ishag, 2Rehab Sir Elkhatim Mustafa, 3Zeinab . E. Nasur, 4*Mashair. E. Ezeldein, 5Malaz Abdulazim Musa
1Department of internal Medicine, Associate Professor. University of Sinnar, Sinnar, Sudan
2Fedail Hospital, Khartoum, Sudan
3Department of of Biochemistry, Sinnar University – Faculty of medicine and health sciences, Sudan
4Department of Biochemistry and Nutrition, Faculty of medicine, University of Gezira, Sudan.
5University of Sinnar, Sinnar Teaching Hospital, MBB
ABSTRACT
Background: Acute kidney injury (AKI) is a critical complication of COVID19, associated with high morbidity and mortality. Data from low resource settings remain scarce.
Objective:To determine the frequency, risk factors, treatment modalities, and outcomes of AKI among hospitalized COVID19 patients in Khartoum,Sudan
Methods:A multicenter crosssectional study was conducted from September to December 2021. Data from 170 hospitalized COVID-19 patients were analyzed using SPSS. AKI was defined and staged using KDIGO criteria.
Results:The frequency of AKI was 66.5% (113/170). Among AKI patients, 69% required renal replacement therapy (RRT), with 51.3% receiving continuous RRT and 48.7% intermittent hemodialysis. Significant predictors of AKI included sepsis (p=0.001) and hemodynamic instability (p=0.001). Mortality was significantly higher in AKI patients (57.5% vs. 31.6%, p=0.001). Comorbidities showed a non-significant trend toward AKI.
Conclusion: AKI is highly prevalent among severe COVID19 patients in Sudan and is associated with markedly increased mortality. Early screening, prompt management of sepsis and hemodynamic instability, and preparedness for RRT are essential in improving outcomes
KEYWORDS
Acute kidney injury, COVID-19, Sudan.
REFERENCES
1) Hirsch JS, et al. Acute kidney injury in patients hospitalized with COVID_19. Kidney Int. 2020;98(1):209-18.
2) Cheng Y, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-38.
3) Gupta S, et al. AKI in COVID_19_associated multisystem inflammatory syndrome in children (MIS-C). Kidney360. 2020;1(7):614-22.
4) Batlle D, et al. Acute kidney injury in COVID_19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol. 2020;31(7):1380-3.
5) Nadim MK, et al. COVID_19_associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol. 2020;16(12):747-64.
6) Silver SA, et al. The Prevalence of Acute Kidney Injury in Patients Hospitalized With COVID_19 Infection: A Systematic Review and Meta_analysis. Kidney Med. 2021;3(1):83-98.
7) Fisher M, et al. AKI in Hospitalized Patients with and without COVID_19: A Comparison Study. J Am Soc Nephrol. 2020;31(9):2145-57.
8) Chan L, et al. AKI in Hospitalized Patients with COVID_. J Am Soc Nephrol. 2021;32(1):151-60.
9) Bowe B, et al. AKI in a National Cohort of Hospitalized US Veterans with COVID-19. Clin J Am Soc Nephrol. 2021;16(1):14-25.
10) Altayb HN, et al. The current situation of COVID_19 in Sudan. New Microbes New Infect. 2021;41:100746.
11) Su H, et al. Renal Histopathological Analysis of 26 Postmortem Findings of Patients with COVID-19 in China. Kidney Int. 2020;98(1):219-27.
12) Ronco C, et al. Management of acute kidney injury in patients with COVID_19. Lancet Respir Med. 2020;8(7):738-42.
13) Hsu CM, et al. Acute kidney injury in patients with COVID_19: a retrospective cohort study from northern Italy. Int Urol Nephrol. 2021;53(8):1693-702.
14) Mohamed MMB, et al. Acute Kidney Injury Associated with Coronavirus Disease 2019 in Urban New Orleans. Kidney360. 2020;1(7):614-22.
15) Villa G, et al. Renal Replacement Therapy in ICU Patients: An Italian Survey. Blood Purif. 2018;45(1-3):242-9.
16) Cheruiyot I, et al. Acute kidney injury is associated with worse prognosis in COVID_19 patients: a systematic review and meta_analysis. Acta Biomed. 2020;91(3):e2020029.
17) Lumlerigul N, et al. Acute kidney injury prevalence, progression and long_term outcomes in critically ill patients with COVID_19: a cohort study. Ann Intensive Care. 2021;11(1):123.
18) Wald R, et al. The Association Between Recovery From Acute Kidney Injury and the Risk of Incident Chronic Kidney Disease Following COVID_19. J Am Soc Nephrol. 2022;33(6):1183-95.
19) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1):1-141.
20) Alhazzani W, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID_19). Intensive Care Med. 2020;46(5):854-87.
21) de Almeida DC, et al. Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients. PLoS One. 2021;16(5):e0251048.
22) Peerapornratana S, et al. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96(5):1083-99.
23) Leedahl DD, et al. Derivation of urine output thresholds that identify a very high risk of AKI in patients with septic shock. Clin J Am Soc Nephrol. 2014;9(7):1168-74.
24) Gaudry S, et al. Continuous renal_replacement therapy versus intermittent hemodialysis in critically ill patients with acu_e kidney injury: a systematic review and meta-analysis. Crit Care. 2020;24(1):528.
25) Robbins_Juarez SY, et al. Outcomes for Patients With COVID_19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis. Kidney Int Rep. 2020;5(8):1149-
60.26. Ahmadian E, et al. COVID_19 and kidney injury: pathophysiology and molecular mechanisms. Rev Med Virol. 2021;31(3):e2176.
